Deal Analysis

Imagine if you had a crystal ball that told you which managed care contracts to sign, how much to offer, and when to walk away. Your bottom line would look substantially better.   Although PharmaMetrics does not have the ability to see into the future, we have a powerful set of "fact-based" software solutions with an underlying  proven methodology that will help you to optimize your pharmaceutical managed care investments.

We give you the ability to project the impact of multiple deal scenarios per customer, contract segment and product in terms of market share, profitability, and other financial metrics. And, we do it faster and easier than other solutions on the market. 

Additionally, once you decide on which deal scenario to negotiate with a Payer, your organization will have the ability to track actual performance versus assumptions.  This will enable you to determine if you are achieving your corporate objectives. 

  •  “What sets PharmaMetrics apart is the depth and breadth of their true business knowledge.”
            -- Director, Contracts, Top 20 Pharma

  • “PharmaMetrics solutions can either be a complete business solution or independent modules that supplement your current business infrastructure.”
            -- Director, Contracts, Top 20 Pharma

  • “The implementation was easy and I didn’t need any training whatsoever. If you know how to do your job – the system follows your process. You don’t have to change your process to meet the systems needs.”
                -- Director, Corporate Compliance, Dermatological Company

  • “The industry experience and knowledge of their expanded team of experts sets them far apart from other service providers within the industry.”
                -- Director of Contracting, Amarin Pharma Inc.

  • “PharmaMetrics offers the services and software to handle all of our Managed Markets needs from front-end pricing analytics to the ban-end contract administration.”
            -- Sr. Director, Contract Management, Top 10 Pharma

  • “The robust reports generated enable more accurate forecasting and financial analysis.”
            -- Sr. Director, Top 10 Pharma